Combination therapy targeting both innate and adaptive immunity improves survival in a pre-clinical model of ovarian cancer

Volume: 7, Issue: 1
Published: Jul 30, 2019
Abstract

Background

Despite major advancements in immunotherapy among a number of solid tumors, response rates among ovarian cancer patients remain modest. Standard treatment for ovarian cancer is still surgery followed by taxane- and platinum-based chemotherapy. Thus, there is an urgent need to develop novel treatment options for clinical translation.

Methods

Our approach was to analyze the effects of standard chemotherapy in the tumor...
Paper Details
Title
Combination therapy targeting both innate and adaptive immunity improves survival in a pre-clinical model of ovarian cancer
Published Date
Jul 30, 2019
Volume
7
Issue
1
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.